Gout And Arigato Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 04-11-2024
- Paid Up Capital ₹ 0.10 M
as on 04-11-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 38.31%
(FY 2023)
- Profit -5.96%
(FY 2023)
- Ebitda 19.25%
(FY 2023)
- Net Worth -27.84%
(FY 2023)
- Total Assets -2.62%
(FY 2023)
About Gout And Arigato
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gulshan Bakhtiani, Prateek Bakhtiani, and Anita Bakhtiani serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC303740
- Company No.
303740
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gout And Arigato?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prateek Bakhtiani  | Managing Director | 05-Jan-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gulshan Bakhtiani | Director | 05-Jan-2018 | Current |
| Anita Bakhtiani | Director | 05-Jan-2018 | Current |
Financial Performance and Corporate Structure Insights of Gout And Arigato.
Gout And Arigato Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.31% increase. The company also saw a slight decrease in profitability, with a 5.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gout And Arigato?
In 2023, Gout And Arigato had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pinnacle Biomed Private LimitedActive 20 years 9 monthsGulshan Bakhtiani and Anita Bakhtiani are mutual person
Wellness Forever Healthtech Private LimitedActive 3 years 4 monthsGulshan Bakhtiani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gout And Arigato?
Unlock and access historical data on people associated with Gout And Arigato, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gout And Arigato, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gout And Arigato's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
